| scholarly article | Q13442814 |
| P50 | author | Gundula Povysil | Q98513882 |
| David B. Goldstein | Q15989762 | ||
| Ali G Gharavi | Q90712104 | ||
| P2093 | author name string | Emily E Groopman | |
| P2860 | cites work | Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion | Q92610443 |
| Clinical use of current polygenic risk scores may exacerbate health disparities | Q92709250 | ||
| Reanalysis of Clinical Exome Sequencing Data | Q92877560 | ||
| Variable prediction accuracy of polygenic scores within an ancestry group | Q93058508 | ||
| Autosomal dominant tubulointerstitial kidney disease | Q93133683 | ||
| The Burden of Candidate Pathogenic Variants for Kidney and Genitourinary Disorders Emerging From Exome Sequencing | Q93375099 | ||
| Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome | Q95819208 | ||
| Genetic testing for kidney disease of unknown etiology | Q98186607 | ||
| Mutations in PAX2 associate with adult-onset FSGS | Q24293179 | ||
| Role of TBX1 in human del22q11.2 syndrome | Q24298685 | ||
| Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease | Q24535574 | ||
| Association of trypanolytic ApoL1 variants with kidney disease in African Americans | Q24606581 | ||
| Large, rare chromosomal deletions associated with severe early-onset obesity | Q24623878 | ||
| Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder | Q24624740 | ||
| Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene | Q24632288 | ||
| Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
| Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia | Q28118506 | ||
| Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis | Q28145709 | ||
| X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study | Q28205352 | ||
| Salt wasting and deafness resulting from mutations in two chloride channels | Q28252859 | ||
| Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report | Q28258261 | ||
| Association between microdeletion and microduplication at 16p11.2 and autism | Q28264205 | ||
| Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing | Q28285241 | ||
| Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease | Q28345772 | ||
| Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome | Q28505391 | ||
| AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis | Q28509528 | ||
| TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome | Q28512803 | ||
| Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development | Q38822009 | ||
| The role of hepatocyte nuclear factor 1β in disease and development. | Q38822493 | ||
| Somatic mutations reveal asymmetric cellular dynamics in the early human embryo | Q38886065 | ||
| Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease | Q38914739 | ||
| Autism genetics: opportunities and challenges for clinical translation | Q39162331 | ||
| Differences in acute kidney injury ascertainment for clinical and preclinical studies. | Q39216951 | ||
| From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health | Q39310748 | ||
| Molecular diagnosis of autosomal dominant polycystic kidney disease | Q39445724 | ||
| An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria | Q39586687 | ||
| Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome | Q39696314 | ||
| DNA copy number variants: A potentially useful predictor of early onset renal failure in boys with posterior urethral valves | Q39781694 | ||
| A population-based approach to assess the heritability and distribution of renal handling of electrolytes | Q40049706 | ||
| Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). | Q40104307 | ||
| Gene Therapy in a Patient with Sickle Cell Disease | Q40313066 | ||
| Alport Syndrome in Women and Girls. | Q41022440 | ||
| Clinical application of whole-exome sequencing across clinical indications | Q41075733 | ||
| Cell lineage of timed cohorts of Tbx6-expressing cells in wild-type and Tbx6 mutant embryos | Q41336033 | ||
| What is complex about complex disorders? | Q42132685 | ||
| Improving genetic diagnosis in Mendelian disease with transcriptome sequencing | Q42343467 | ||
| hnf1b genes in zebrafish hindbrain development | Q42582598 | ||
| COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome | Q42676814 | ||
| Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation | Q43136777 | ||
| Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities | Q43842493 | ||
| Hypertensive nephrosclerosis in African Americans versus Caucasians | Q44039626 | ||
| Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling | Q44053821 | ||
| Multilocus polycystic disease | Q44412153 | ||
| Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome | Q44609185 | ||
| Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study | Q45038717 | ||
| Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators | Q46250134 | ||
| Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations | Q47073818 | ||
| Genomic medicine for kidney disease | Q47200436 | ||
| Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study | Q47200770 | ||
| Genetic basis of human congenital anomalies of the kidney and urinary tract | Q47224735 | ||
| Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice | Q47444849 | ||
| Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases | Q47781166 | ||
| Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. | Q47997703 | ||
| Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease | Q47999439 | ||
| Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. | Q48041792 | ||
| The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. | Q48056738 | ||
| Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome. | Q48370106 | ||
| Duplications of SLC1A3: Associated with ADHD and autism. | Q48680280 | ||
| Exome Sequencing Discerns Syndromes in Patients from Consanguineous Families with Congenital Anomalies of the Kidneys and Urinary Tract. | Q49398765 | ||
| Renin cells in homeostasis, regeneration and immune defence mechanisms. | Q49584053 | ||
| The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations. | Q50208692 | ||
| Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness. | Q50337200 | ||
| Study of the True Clinical Progression of Autosomal Dominant Alport Syndrome in a European Population. | Q50352053 | ||
| Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. | Q50447866 | ||
| Copy-number variation associated with congenital anomalies of the kidney and urinary tract. | Q50631353 | ||
| Chronic Kidney Disease. | Q51043966 | ||
| Pathogenic Germline Variants in 10,389 Adult Cancers. | Q52602399 | ||
| Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders. | Q52622713 | ||
| Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. | Q52650061 | ||
| Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. | Q52715894 | ||
| A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. | Q52804042 | ||
| Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat. | Q53843470 | ||
| 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort. | Q54060427 | ||
| Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. | Q54060993 | ||
| Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report. | Q55601184 | ||
| Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations | Q56658122 | ||
| A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function | Q57023947 | ||
| Genome-wide polygenic risk predictors for kidney disease | Q57048905 | ||
| Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome | Q28587462 | ||
| LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum | Q28588972 | ||
| Three neural tubes in mouse embryos with mutations in the T-box gene Tbx6 | Q28589973 | ||
| Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy | Q28943554 | ||
| Insights into kidney diseases from genome-wide association studies | Q30248678 | ||
| The Genetic Landscape of Renal Complications in Type 1 Diabetes | Q30275890 | ||
| Lhx1 controls terminal differentiation and circadian function of the suprachiasmatic nucleus | Q30604681 | ||
| Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. | Q31116359 | ||
| The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat | Q33567658 | ||
| Heritability of urinary traits that contribute to nephrolithiasis | Q33571796 | ||
| Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations | Q33722167 | ||
| Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes | Q33739493 | ||
| The genetics of autism: key issues, recent findings, and clinical implications | Q33739608 | ||
| Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia | Q33740241 | ||
| Alport syndrome cold cases: Missing mutations identified by exome sequencing and functional analysis | Q33751925 | ||
| Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. | Q33886219 | ||
| Sequencing studies in human genetics: design and interpretation. | Q33981063 | ||
| X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome | Q33988983 | ||
| Rare inherited kidney diseases: challenges, opportunities, and perspectives | Q34054113 | ||
| Describing the genetic architecture of epilepsy through heritability analysis | Q34174911 | ||
| An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. | Q34208328 | ||
| Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele | Q34211184 | ||
| Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus | Q34212342 | ||
| Mutations in multiple PKD genes may explain early and severe polycystic kidney disease | Q34228262 | ||
| Familial clustering of ESRD in the Norwegian population | Q34292853 | ||
| Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. | Q34328696 | ||
| Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity | Q34498881 | ||
| Coming of age: ten years of next-generation sequencing technologies | Q34526801 | ||
| Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease | Q34529587 | ||
| Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis | Q34577537 | ||
| Genetic Drivers of Kidney Defects in the DiGeorge Syndrome | Q34680591 | ||
| TBX6 null variants and a common hypomorphic allele in congenital scoliosis | Q35078357 | ||
| Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease | Q35088150 | ||
| Genomic imbalances in pediatric patients with chronic kidney disease | Q35720119 | ||
| The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees | Q36003176 | ||
| Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. | Q36299446 | ||
| A COL4A5 mutation with glomerular disease and signs of chronic thrombotic microangiopathy | Q36306757 | ||
| A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders | Q36386207 | ||
| Copy-number disorders are a common cause of congenital kidney malformations | Q36451480 | ||
| Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy | Q36492215 | ||
| Germline Mutations in Predisposition Genes in Pediatric Cancer | Q36524309 | ||
| The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. | Q36624712 | ||
| DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease | Q36800496 | ||
| Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation | Q36836682 | ||
| Clan genomics and the complex architecture of human disease | Q36851578 | ||
| Type of PKD1 mutation influences renal outcome in ADPKD. | Q36880400 | ||
| Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease | Q36944701 | ||
| A wide spectrum of phenotypes in a family with renal coloboma syndrome caused by a PAX2 mutation. | Q36982079 | ||
| Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder | Q37026249 | ||
| The modern spectrum of renal biopsy findings in patients with diabetes | Q37212364 | ||
| COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | Q37340191 | ||
| The continuum of causality in human genetic disorders | Q37422176 | ||
| The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. | Q37640927 | ||
| Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci | Q37658904 | ||
| Whole-exome resequencing distinguishes cystic kidney diseases from phenocopies in renal ciliopathies | Q37678462 | ||
| Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation | Q37679283 | ||
| Renal coloboma syndrome. | Q37886657 | ||
| Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. | Q37972823 | ||
| Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. | Q38263926 | ||
| HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. | Q38299096 | ||
| The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease | Q38373599 | ||
| Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development | Q38528125 | ||
| Genetic, environmental, and epigenetic factors involved in CAKUT. | Q38568437 | ||
| Detection of structural mosaicism from targeted and whole-genome sequencing data | Q38601700 | ||
| Uromodulin: from physiology to rare and complex kidney disorders | Q38638219 | ||
| Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. | Q38644619 | ||
| Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. | Q38657443 | ||
| Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. | Q38764367 | ||
| Developing Treatments for Chronic Kidney Disease in the 21st Century | Q38781550 | ||
| Noninvasive Immunohistochemical Diagnosis and Novel Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease | Q57164422 | ||
| Expert consensus guidelines for the genetic diagnosis of Alport syndrome | Q57176794 | ||
| ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation | Q57455550 | ||
| Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank | Q57808513 | ||
| Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations | Q57910661 | ||
| Molecular genetics of 22q11.2 deletion syndrome | Q58124159 | ||
| Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases | Q58620406 | ||
| Accurate classification of BRCA1 variants with saturation genome editing | Q59068795 | ||
| CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I | Q60300357 | ||
| Phenotype risk scores identify patients with unrecognized Mendelian disease patterns | Q60800108 | ||
| Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS | Q63869352 | ||
| Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis | Q64097676 | ||
| Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting | Q64234829 | ||
| Renal biopsy findings in presumed hypertensive nephrosclerosis | Q72173122 | ||
| Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome | Q80848101 | ||
| Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5 | Q81402655 | ||
| The Irish Kidney Gene Project--Prevalence of Family History in Patients with Kidney Disease in Ireland | Q85642821 | ||
| Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis | Q86084087 | ||
| Chapter 1: Definition and classification of CKD | Q87393507 | ||
| The personal and clinical utility of polygenic risk scores | Q88778863 | ||
| Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis | Q89419396 | ||
| Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis | Q89419413 | ||
| Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children | Q90004529 | ||
| Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen | Q90182401 | ||
| Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion | Q90319801 | ||
| A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants | Q90351343 | ||
| Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome | Q90391342 | ||
| Genetic regulatory variation in populations informs transcriptome analysis in rare disease | Q90638861 | ||
| Polygenic burden in focal and generalized epilepsies | Q90686302 | ||
| The copy number variation landscape of congenital anomalies of the kidney and urinary tract | Q90712113 | ||
| Anomalies of the genitourinary tract in children with 22q11.2 deletion syndrome | Q90734423 | ||
| Diagnostic Utility of Exome Sequencing for Kidney Disease | Q90756992 | ||
| Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction | Q90759657 | ||
| Noncoding rare variants of TBX6 in congenital anomalies of the kidney and urinary tract | Q90858635 | ||
| Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease | Q91234891 | ||
| Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases | Q91322118 | ||
| Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension st | Q91361732 | ||
| Monogenic causes of chronic kidney disease in adults | Q91655484 | ||
| Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome | Q91930824 | ||
| Personalized medicine in chronic kidney disease by detection of monogenic mutations | Q91950321 | ||
| Intrafamilial Variability of ADPKD | Q91976657 | ||
| Autosomal dominant polycystic kidney disease | Q92019794 | ||
| Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system | Q92061449 | ||
| A catalog of genetic loci associated with kidney function from analyses of a million individuals | Q92451898 | ||
| Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts | Q92503625 | ||
| ALG9 Mutation Carriers Develop Kidney and Liver Cysts | Q92507478 | ||
| Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD | Q92544416 | ||
| P577 | publication date | 2020-08-17 | |
| P1433 | published in | Nature Reviews Nephrology | Q2079275 |
| P1476 | title | Rare genetic causes of complex kidney and urological diseases |
Search more.